On May 27, Mao Geping (01318.HK) fell 5.12% in regular trading, trading at 56.55 HKD/share, with trading volume of approximately 68.43 million HKD.

The decline follows continued selling pressure stemming from a major shareholder placement on May 15, when shareholders Ding Tao and Xu Kejun sold 9.87 million shares at 63.3-65 HKD per share via JP Morgan, triggering a near-17% single-day plunge at the time. While the stock briefly rebounded over 5% on May 22 as market sentiment appeared to stabilize, the recovery has proven short-lived. The stock remains well below the placement price, suggesting ongoing investor concern about further supply overhang.

Sector-wide weakness also contributed, with the Personal Products industry broadly declining. Among peers, GIANT BIOGENE fell 1.54%, BUTONG GROUP dropped 4.02%, HENGAN INT'L slipped 0.16%, CHICMAX declined 2.33%, and SOFTCARE lost 4.02%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)